Julian S. Gangolli is CVP & Pres & North America at ALLERGAN INC (AGN). They have made 5 open-market trades across 3 companies since 2012, most recently 2025-02-06.
CIK 0001532023
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRYS | SELL | 2024-05-20 | 2024-05-22 | $164.14 | $6.6M | -5.0% | +3.1% | +17.4% |
| GWPH | SELL | 2019-05-10 | 2019-05-14 | $14.84 | $10.0M | +4.6% | +0.1% | -9.2% |
| GWPH | SELL | 2019-05-10 | 2019-05-14 | $14.84 | $10.0M | +4.6% | +0.1% | -9.2% |
| GWPH | SELL | 2019-02-26 | 2019-02-28 | $12.45 | $149K | -1.4% | -3.1% | +4.3% |
| AGN | SELL · 10b5-1 | 2013-12-27 | 2013-12-30 | $110.05 | $5.8M | -6.3% | +0.3% | +0.3% |
| AGN | SELL | 2012-11-27 | 2012-11-29 | $91.89 | $8.3M | -6.3% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.